If your gums bleed when you brush, if your dentist has flagged deeper pockets, or if you simply want a better read on the inflammation quietly running in your body, this is one of the most informative things you can measure. P. gingivalis (Porphyromonas gingivalis) is a single bacterium with an outsized effect on human health. It is the organism most consistently tied to severe periodontitis, the form of gum disease that destroys the bone holding your teeth in place.
Its reach does not stop at your mouth. Research has identified this organism, its DNA, or its toxic enzymes in atherosclerotic plaques and in postmortem brain tissue from people with Alzheimer's disease, suggesting that what starts as a quiet oral infection may seed inflammation far from where it began.
A saliva sample is analyzed using quantitative PCR or related techniques that count the number of P. gingivalis cells (or copies of its DNA) per milliliter of saliva. Saliva is used because it pools bacteria from the entire mouth, giving a broader snapshot than a swab from a single gum pocket. A higher salivary level generally reflects either heavier colonization, deeper infected pockets, or both.
The test does not measure inflammation directly. It measures the bacterial load of an organism whose presence and abundance closely track the severity of periodontal disease and may have downstream effects on heart and brain health.
Salivary P. gingivalis is one of the most accurate microbial markers for periodontitis available today. In a 2025 systematic review and meta-analysis of saliva-based studies, this single bacterium reached a combined sensitivity of 84.2% and specificity of 85.4% for distinguishing periodontitis from health, with an area under the curve of 0.864 (where 1.0 would be a perfect test). In other words, measuring this one organism alone caught the majority of cases while keeping false positives uncommon.
A chair-side saliva test built around this bacterium reported sensitivity of 92% and specificity of 96% compared with laboratory PCR at a threshold of about 100,000 P. gingivalis cells per milliliter. Salivary counts above this level have been linked in research to active disease progression, and population studies in Japan found that the amount of P. gingivalis showed the strongest association with deepened pockets, bleeding on probing, and bone loss among all the red-complex bacteria tested.
What this means for you: bleeding gums, recurrent bad breath, or a recent diagnosis of moderate to severe periodontitis are all reasons to know your number. Tracking it over time tells you whether the bacterium is actually retreating after treatment, not just whether your gums look better at the dentist.
P. gingivalis DNA has been detected in roughly 50% of atherosclerotic plaque samples taken from coronary arteries during planned surgery, making it the most prevalent periodontal organism found in plaque. This does not prove the bacterium caused the plaque, but it places it at the scene of the disease.
A cross-sectional study of 460 patients found that detecting P. gingivalis DNA in blood (a sign of the bacterium escaping the mouth into the bloodstream) was associated with about 1.9 times the odds of having an acute myocardial infarction, after adjusting for traditional risk factors. A separate clinical study of preventive cardiology patients found that those with established coronary artery disease who were positive for P. gingivalis had higher levels of high-sensitivity C-reactive protein and myeloperoxidase, two markers tracking vascular inflammation.
What this means for you: if you already carry cardiovascular risk factors, a positive or elevated salivary result is a piece of your inflammatory picture worth knowing. Pair it with hs-CRP (high-sensitivity C-reactive protein, a general marker of body-wide inflammation) to understand whether your gum bacteria may be quietly adding to your vascular workload.
This connection is the most provocative and the most preliminary. In a landmark study, researchers identified gingipains (the toxic enzymes produced by P. gingivalis) in over 90% of postmortem brain samples from people with Alzheimer's disease, and the level of these enzymes correlated with the amount of tau and ubiquitin pathology, two hallmarks of the disease. The bacterium itself, or its DNA, has also been detected in the cerebrospinal fluid of people diagnosed with Alzheimer's.
Most of the mechanistic evidence that this bacterium can actually cause Alzheimer's-like changes comes from animal studies, where oral or systemic infection produced amyloid plaques, increased inflammatory cytokines in the brain, and worsened performance on memory tasks. The leap from postmortem human findings and mouse models to a direct causal role in human disease has not yet been fully made.
What this means for you: a high salivary level is not a diagnosis of future cognitive decline. It is a modifiable factor in a pathway that an active area of research is exploring. Reducing the burden of this organism by treating periodontal disease aggressively is a low-cost intervention with clear oral health benefits and possible neurological ones.
There is no universally adopted clinical cutpoint for salivary P. gingivalis. The most-cited threshold comes from chair-side diagnostic work, which used 100,000 cells per milliliter (10^5 CFU/mL) as the point at which detection strongly correlated with active disease progression. Different labs use different assays (qPCR, ELISA, sequencing), and absolute counts cannot always be compared across methods.
| Level | Approximate Range | What It Suggests |
|---|---|---|
| Undetected or very low | Below 10,000 cells/mL | Generally consistent with periodontal health, though not a guarantee |
| Moderate carriage | 10,000 to 100,000 cells/mL | Oral colonization present, monitor closely especially if other gum disease signs exist |
| Elevated | Above 100,000 cells/mL | Threshold associated with periodontitis activity and progression in research studies |
These ranges are illustrative orientation based on research thresholds, not a regulatory standard. Your lab will use its own assay-specific reference values. The most meaningful comparison is your own level over time, measured by the same lab using the same method.
A single measurement tells you whether the bacterium is currently abundant in your saliva. The trend tells you something more useful: whether your treatment is actually working at the microbial level, not just the visible gum level. Studies of scaling and root planing show that salivary and subgingival P. gingivalis drop significantly at 3 months and remain lower through 12 months when good maintenance follows.
Get a baseline before starting any periodontal treatment or oral hygiene intervention. Retest at 3 months to confirm the bacterium is being suppressed. Retest again at 6 to 12 months to see whether you are holding the gain. After that, at least annual retesting is reasonable for anyone with a history of periodontitis or systemic risk factors.
An elevated salivary level alongside any clinical signs of gum disease (bleeding, deepening pockets, gum recession, persistent bad breath) is a clear signal to escalate. The standard next step is a thorough periodontal evaluation, which typically involves probing each tooth to measure pocket depth and looking for bone loss on dental imaging. From there, scaling and root planing is the foundational treatment.
If you are also working on cardiovascular or cognitive health, consider testing your hs-CRP (a marker of systemic inflammation) and reviewing your full inflammatory picture with your physician. A persistently elevated salivary level despite aggressive home care and dental cleaning is the kind of finding worth bringing to a periodontist, who can offer adjunctive therapies including locally delivered antimicrobials, photodynamic therapy, or short-course systemic antibiotics in carefully selected cases.
Evidence-backed interventions that affect your Porphyromonas gingivalis level
Porphyromonas gingivalis is best interpreted alongside these tests.